|

VCN-01 oncolytic adenovirus (zabilugene almadenorepvec) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Theriva Biologics SL1

Indications

  • Ductal Adenocarcinoma of the Pancreas1
  • Pancreas Cancer, Metastatic1
  • Pancreas Cancer, Stage IV1
  • Cancer1

Other1 trial

A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.